41，Stephman-Breen CO,Sherrard D,Walker A, et al. Racial differences in bone mineral density and bone loss among end-stage renal disease pationts. Am J Kidn Dis 1999,33(5):941-946.
52，Lindberg JS,Moe SM. Osteoporosis in end-stage renal disease. 1999,19(2):115-122.
63，Chen CC,Wang SS,Jeng FS,et al. Metabolic bone disease of liver cirrhosis:is it parallel to the clinical severity of cirrhosis? Gastroenterol Hepatol 1996,11(5):417-421.
74，Shane E,Maneini D,Aaronson K, et al. Bone mass,vitamin D deficiency,and hyperparathyroidism in congestive heart failure. Am J Med, 1997,103(3):197-207.
85，Watson KE,Abrolat ML,Malone LL,et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997,96(6):1755-1760.
96，Shane E,Silverberg SJ,Donovan D, et al. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med,1996,101(3):262-269.
107，Uebelhart D,Demiaux-Domenech B,Roth M et al. Bone metabolism in spinal cord injured individuals and in others who have prolonged immobilisation: a review. Paraplegia 1995,33(11):669-673.
9Yamagishi S,Nakamura K,Inoue H.Possible participation of advanced glycationend products in the pathogenesis of osteoporosis in diabetic patients[J].Medical Hypotheses,2005,65(6):1013.
10Jorgensen L,Joakimsen O,Rosvold Berntsen GK,et al..Low bone mineral density is related to echogenic carotid artery plaques:a population-based study[J].Am J Epidemiol,2004,160(6):549.
